Authors
- . Hatav Gasemi Tehrani
- . Maryam Allahdadian 1
- . Farzane Zarre 2
- . Hanie Ranjbar 2
- . Fateme Allahdadian 2
1 Department of Midwifery, Islamic Azad University Falavarjan Branch
2 Department of Midwifery, School of Nursing and Midwifery Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
BACKGROUND AND OBJECTIVE: Polycystic ovarian syndrome (PCOS) is the common cause of
Oligo‑ovulation. This syndrome causes long‑term metabolic issues as well as increase the risk of
diabetes type 2, hypertension, dyslipidemia, and cardiovascular disease. The current research aimed
to study the effect of green tea on weight and hormonal changes of women suffering from PCOS.
METHODS: This two group, double‑blind, randomized clinical trial was conducted in Isfahan city.
Overweight women suffering from PCOS (n = 60) were randomly divided into two groups. Green
tea was prescribed to the experimental group, and placebo was prescribed to the control group.
Free testosterone hormones and fasting insulin were compared in both groups at the beginning and
12 weeks after the study commencement. The weight of participants of both groups was also measured
before and after the study. The statistical data were analyzed by SPSS software and paired t‑test.
RESULTS: The paired t‑test showed that there was no significant difference in the mean weight
of both groups before the intervention (P = 0.812), but the difference was significant after the
intervention (P = 0.031). There was no significant difference in the mean fasting insulin of both groups
before the intervention (P = 0.352), but the difference was significant after the intervention (P < 0.0001).
Moreover, there was no significant difference in the mean free testosterone level of both groups before
the intervention (P = 0.638), but the difference was significant after the intervention (P < 0.0001).
CONCLUSION: The consumption of green tea by overweight and obese women suffering from PCOS
leads to weight loss, a decrease in fasting insulin, and a decrease in the level of free testosterone.
Keywords
Continuing metformin throughout pregnancy in women with
polycystic ovary syndrome appears to safely reduce first‑trimester
spontaneous abortion: A pilot study. Fertil Steril 2001;75:46‑52.
2. Sohrabvand F, Aghsa MM, Haghollahi F, Bagheri M, Shariat M,
Alyasin A, et al. Evaluating course of pregnancy in women with
infertility due to PCOS and on metformin. J Reprod Infertil
2007;8:23‑29.
3. Hamayeli H, Tahbaz F, Salehpour S. Changes in sex hormones in
overweight and obese women with polycystic ovary syndrome after
taking two low calorie diet. J Endocrinol Metab Iran 2010;12:160‑8.
4. Mohamadzade M, Safdarian L. Management of polycystic ovary
syndrome. Prof J Obstet Gynecol 2010;5:51‑66.
5. Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the
risk for polycystic ovary syn‑drome. J Clin Endocrinol Metab
2008;93:162‑8.
6. Svendsen PF, Nilas L, Madsbad S, Holst JJ. Incretin hormone
secretion in women with polycystic ovary syndrome: Roles
of obesity, insulin sensitivity, and treatment with metformin.
Metabolism 2009;58:586‑93.
7. Pehlivanov B, Mitkov M. Serum leptin levels correlate with
clinical and biochemical indices of insulin resistance in women
with polycystic ovary syndrome. Eur J Contracept Reprod Health
Care 2009;14:153‑9, 256.
8. Lakhani K, Hardiman P, Seifalian AM. Intim‑amedia thickness
of elastic and muscular arteries of young women with polycystic
ovaries. Atherosclerosis 2004;175:353‑9.
9. Mousumi B, Joshua D, Jihyeung JU, Kenneth R.Reuhl, Sue A.
Shapses, Chung s. Yang.et al. The major green tea polyphenol,
epigallocatechin‑3‑gallate inhibits obesity, metabolic syndrome,
and fatty liver disease in high‑fat‑fed mice. J Nutr 2008;138:1677‑83.
10. Kim MJ, Yoo KH, Park HS, Chung SM, Jin CJ, Lee Y, et al. Plasma
adiponectin and insulin resistance in Korean type 2 diabetes
mellitus. Yonsei Med J 2005;46:42‑50.
11. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS.
The major green tea polyphenol, (‑)‑epigallocatechin‑3‑gallate,
inhibits obesity, metabolic syndrome, and fatty liver disease in
high‑fat‑fed mice. J Nutr 2008;138:1677‑83.
12. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, et al.
Effects of dietary supplementation with the green tea polyphenol
epigallocatechin‑3‑gallate on insulin resistance and associated
metabolic risk factors: Randomized controlled trial. Br J Nutr
2009;101:886‑94.
13. Kianbakht S. A review of the medicinal plants used in the
treatment of obesity and over‑weight. J Med Plants 2010;9:36.
14. Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea
catechins: A mechanistic review. J Nutr Biochem 2011;22:1‑7.
15. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, et al.
Efficacy of a green tea extract rich in catechin polyphenols and
caffeine in increasing 24‑h energy expenditure and fat oxidation
in humans. Am J Clin Nutr 1999;70:1040‑5.
16. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC. Effects
of Chinese green tea on weight, and hormonal and biochemical
profiles in obese patients with polycystic ovary syndrome – A
randomized placebo‑controlled trial. J Soc Gynecol Investig
2006;13:63‑8.
17. Auvichayapat P, Prapochanung M, Tunk‑Amnerdthai O,
Sripandikulchai B, Auvichayapat N, Thinkhamrop B, et al.
Effectiveness of green tea on weight reduction in obese Thais:
A ran‑domized, controlled trial. Physiol Behav 2008;93:486‑91.
18. Hursel R, Viechtbauer W, Westerterp‑Plantenga MS. The
effects of green tea on weight loss and weight maintenance: A
meta‑analysis. Int J Obes (Lond) 2009;33:956‑61.
19. Hininger‑Favier I, Benaraba R, Coves S, Anderson RA,
Roussel AM. Green tea extract decreases oxidative stress and
improves insulin sensitivity in an animal model of insulin
resistance, the fructose‑fed rat. J Am Coll Nutr 2009;28:355‑61.
20. Figueiroa M, César Vieira J, Leite D, Andrade Filho A. Green tea
polyphenols inhibit testosterone production in rat leydig cells.
J Nutr 2009;11:362‑70.
21. Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC.
Effect of 2‑month controlled green tea intervention on
lipoprotein cholesterol, glucose, and hormone levels in healthy
postmenopausal women. Cancer Prev Res (Phila) 2012;5:393‑402.
)